Psychiatry and Neurology, Epilepsy · Los Angeles, CA
NPI
1205877917
Since 2006
Specialty
Psychiatry and Neurology, Epilepsy
Code 2084E0001X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1520 San Pablo St, Suite 3000
Los Angeles, CA, 90033
Phone (323) 442-5710
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
390 services
Medicare patients, 2024
158
Average age 61
Drug cost, 2024
$1.1M
1,874 prescriptions
Company payments, 2025
$234
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laura A Kalayjian was code 99214 (office e&m - established), 125 times for 63 patients. In total Laura A Kalayjian billed 390 services in 21 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 125 | 63 | $63.30 | $7,913 |
| 99214 Office E&M - Established | Office | 52 | 34 | $71.76 | $3,732 |
| 95816 Neurologic | Facility | 45 | 41 | $47.34 | $2,130 |
| 95720 Neurologic | Facility | 40 | 22 | $171.78 | $6,871 |
| 95819 Neurologic | Facility | 25 | 24 | $47.32 | $1,183 |
| 95970 Electrical Nerve Conductivity | Facility | 25 | 12 | $12.71 | $318 |
By year: 2022 $15K for 184 services; 2023 $35K for 412 services; 2024 $27K for 390 services.
Medicare prescription drug claims, 2024
In 2024, the drug Laura A Kalayjian prescribed most often to Medicare patients was Lacosamide, with 148 prescriptions and refills. In total Laura A Kalayjian wrote 1,874 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lacosamide Generic | 148 | 198 | 23 | $17K |
| Levetiracetam Generic | 110 | 216 | 31 | $5,726 |
| Lamotrigine Generic | 83 | 195 | 25 | $1,632 |
| Clonazepam Generic | 81 | 107 | 16 | $504 |
| Lamotrigine Er Lamotrigine | 81 | 121 | 11 | $22K |
| Topiramate Generic | 79 | 140 | 13 | $1,130 |
| Gabapentin Generic | 72 | 102 | 13 | $649 |
| Clobazam Generic | 65 | 81 | Under 11 | $3,724 |
| Lorazepam Generic | 60 | 63 | Under 11 | $246 |
| Levetiracetam Er Levetiracetam | 59 | 89 | 11 | $4,574 |
| Fycompa Perampanel | 58 | 81 | Under 11 | $93K |
| Pregabalin Generic | 57 | 88 | 15 | $1,335 |
| Zonisamide Generic | 54 | 114 | Under 11 | $1,912 |
| Briviact Brivaracetam | 49 | 59 | Under 11 | $71K |
| Vimpat Lacosamide | 45 | 53 | Under 11 | $54K |
Brand drugs: 470 claims; generic drugs: 1,364 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laura A Kalayjian $234 ($234 in general payments such as food, travel and fees) from 1 company. The largest payer was LivaNova USA, Inc. with $234.
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. LIVN | 28 | $234 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.